 |
|
Survival analysis of spinal muscular atrophy type I
Hyun Bin Park (Park HB), Soon Min Lee (Lee SM), Jin Sung Lee (Lee JS), Min Soo Park (Park MS), Kook In Park (Park KI), Ran Namgung (Namgung R), Chul Lee (Lee C)
Clin Exp Pediatr. 2010;53(11):965-970. Published online 2010 Nov 30 DOI: https://doi.org/10.3345/kjp.2010.53.11.965
|
|
Citations to this article as recorded by
 Nusinersen therapy changed the natural course of spinal muscular atrophy type 1: What about spine and hip?
Niyazi Erdem Yasar, Guzelali Ozdemir, Elif Uzun Ata, Mustafa Okan Ayvali, Naim Ata, Mahir Ulgu, Ebru Dumlupınar, Suayip Birinci, Izzet Bingol, Senol Bekmez
Journal of Children's Orthopaedics.2024; 18(3): 322. CrossRef Adeno-associated virus as a delivery vector for gene therapy of human diseases
Jiang-Hui Wang, Dominic J. Gessler, Wei Zhan, Thomas L. Gallagher, Guangping Gao
Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef Survival analysis and life expectancy of pediatric patients with spinal muscular atrophy in Thailand
Piyanart Sittiyuno, Pimchanok Kulsirichawaroj, Pattara Leelahavarong, Oranee Sanmaneechai
Heliyon.2024; 10(11): e32732. CrossRef Onasemnogene Abeparvovec Gene Therapy and Risdiplam for the Treatment of Spinal Muscular Atrophy in Thailand: A Cost-Utility Analysis
Sarayuth Khuntha, Juthamas Prawjaeng, Kunnatee Ponragdee, Oranee Sanmaneechai, Varalak Srinonprasert, Pattara Leelahavarong
Applied Health Economics and Health Policy.2024;[Epub] CrossRef Disease Burden of Spinal Muscular Atrophy: A Comparative Cohort Study Using Insurance Claims Data in the USA
Julie Mouchet, Spyros Roumpanis, Eleni Gaki, Scott Lipnick, Maryam Oskoui, Renata S. Scalco, Basil T. Darras
Journal of Neuromuscular Diseases.2023; 10(1): 41. CrossRef Brain-protective mechanisms of autophagy associated circRNAs: Kick starting self-cleaning mode in brain cells via circRNAs as a potential therapeutic approach for neurodegenerative diseases
Rabea Basri, Faryal Mehwish Awan, Burton B. Yang, Usman Ayub Awan, Ayesha Obaid, Anam Naz, Aqsa Ikram, Suliman Khan, Ijaz ul Haq, Sadiq Noor Khan, Muslim Bin Aqeel
Frontiers in Molecular Neuroscience.2023;[Epub] CrossRef Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management
Noman Paracha, Pollyanna Hudson, Stephen Mitchell, C. Simone Sutherland
PharmacoEconomics.2022; 40(S1): 11. CrossRef Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1
Antonio Corsello, Lorenzo Scatigno, Martina Chiara Pascuzzi, Valeria Calcaterra, Dario Dilillo, Sara Vizzuso, Gloria Pelizzo, Elena Zoia, Anna Mandelli, Annalisa Govoni, Alessandra Bosetti, Ruggiero Francavilla, Flavia Indrio, Valentina Fabiano, Gian Vinc
Nutrients.2021; 13(7): 2400. CrossRef Pathologic Alterations in the Proteome of Synaptosomes from a Mouse Model of Spinal Muscular Atrophy
Mehdi Eshraghi, Robert Gombar, Yves De Repentigny, Panayiotis O. Vacratsis, Rashmi Kothary
Journal of Proteome Research.2019; 18(8): 3042. CrossRef Healthcare utilisation in children with SMA type 1 treated with nusinersen: a single centre retrospective review
Imran Ali, Francis J Gilchrist, William D Carroll, John Alexander, Sadie Clayton, Richa Kulshrestha, Tracey Willis, Martin Samuels
BMJ Paediatrics Open.2019; 3(1): e000572. CrossRef A Semi‐Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy
Konstantinos Biliouris, Puneet Gaitonde, Wei Yin, Daniel A. Norris, Yanfeng Wang, Scott Henry, Robert Fey, Ivan Nestorov, Stephan Schmidt, Mark Rogge, Lawrence J. Lesko, Mirjam N. Trame
CPT: Pharmacometrics & Systems Pharmacology.2018; 7(9): 581. CrossRef 218th ENMC International Workshop:
Richard S. Finkel, Thomas Sejersen, Eugenio Mercuri, E. Bertini, K. Chen, T.O. Crawford, V. Dubowitz, M. de Lemus, R. Graham, R. Hurst Davis, S. Iannaccone, J. Kirschner, M. Main, O. Mayer, E. Mazzone, J. Montes, F. Muntoni, A. Murphy, S. Quijano-Roy, A.
Neuromuscular Disorders.2017; 27(6): 596. CrossRef Placental development in a mouse model of spinal muscular atrophy
Gerialisa Van Gronigen Caesar, Jeffrey M. Dale, Erkan Y. Osman, Michael L. Garcia, Christian L. Lorson, Laura C. Schulz
Biochemical and Biophysical Research Communication.2016; 470(1): 82. CrossRef Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review
Chia-Wei Lin, Stephanie J. Kalb, Wei-Shi Yeh
Pediatric Neurology.2015; 53(4): 293. CrossRef Demographic characteristics of SMA type 1 patients at a tertiary center in Turkey
Barış Ekici, Betül Bozkurt, Burak Tatlı, Mine Çalışkan, Nur Aydınlı, Meral Özmen
European Journal of Pediatrics.2012; 171(3): 549. CrossRef
|